PARACANIS X 5 ML
PARACANIS X 5 ML
Para perros y gatos
como antiparasitarios para el tratamiento de infestaciones ocasionadas por tenias,
Ascaris spp y Ancylostomas spp.
COMPOSICIÓN:
![](data:image/png;base64,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)
DOSIS:
Debe administrarse vía oral, 1 ml por cada 5 Kg de peso vivo.
PRESENTACIÓN:
Jeringa por 2, 5 y 10 ml.
Su fragmento dinámico se mostrará aquí...
Este mensaje se muestra porque no proporcionó un filtro y una plantilla para usar.